Treatment and Improved Outcomes of Three Adult Patients With Guanidinoacetate Methyltransferase (GAMT) Deficiency
ABSTRACT Guanidinoacetate methyltransferase (GAMT) deficiency is a creatine synthesis disorder caused by biallelic pathogenic variants in GAMT. Early diagnosis and treatment can lead to normal neurocognitive outcomes, which has prompted its recent addition to the Recommended Uniform Screening Panel....
Saved in:
| Main Authors: | Angela Lee, Judith Weisenberg, Elizabeth Toolan, Marwan Shinawi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | JIMD Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jmd2.70019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamic electro‐clinical features in Guanidinoacetate N‐methyltransferase deficiency: A familial case series
by: Mariapaola Schifino, et al.
Published: (2025-08-01) -
Intratesticular creatine maintains spermatogenesis by defining tight junctions
by: Sohei Kuribayashi, et al.
Published: (2024-12-01) -
GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma
by: Bin Zheng, et al.
Published: (2025-04-01) -
Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency
by: Zahra Nasseri Moghaddam, et al.
Published: (2025-08-01) -
Effect of Guanidinoacetic Acid Supplementation on the Performance of Calves Fed Milk Replacer
by: Kathryn J. Hazlewood, et al.
Published: (2024-09-01)